Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Purpose To evaluate the safety and efficacy of CT-2103, a novel conjugate of paclitaxel and poly-l-glutamic acid, in heavily pretreated patients with recurrent ovarian, fallopian tube, or peritoneal cancer. Patients and Methods Ninety-nine patients with measurable disease received intravenous CT-210...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Ingarihi |
| I whakaputaina: |
2004
|
| Urunga tuihono: | https://doi.org/10.1200/jco.2004.12.043 https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.12.043?role=tab |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|